Gene expression profiling (GEP) for the prediction of response to neoadjuvant paclitaxel and gemcitabine in breast cancer (BC). Preliminary results from a Phase II trial

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 22; no. 14_suppl; p. 580
Main Authors	Llombart-Cussac, A., Moreno-Bueno, G., Ruiz, A., Albanell, J., Mayordomo, J. I., Carñana, V., Guillem, V., Diaz-Uriarte, R., Palacios, J., Garcia-Ribas, I.
Format	Journal Article
Language	English
Published	15.07.2004
Online Access	Get full text

Loading…